{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:12:01Z","timestamp":1790197921287,"version":"4.1.0"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002642","name":"Korea University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002642","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Research & Clinical Practice"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.orcp.2026.09.004","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:49:22Z","timestamp":1789764562000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic determinants of GLP-1 responsiveness: Integrating dietary modulation beyond genetics"],"prefix":"10.1016","author":[{"given":"Hyo Ri","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Yoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyongpil","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ui-Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Woo","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2837-9302","authenticated-orcid":false,"given":"Jae Kyeom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.orcp.2026.09.004_bib1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"New Engl J Med"},{"key":"10.1016\/j.orcp.2026.09.004_bib2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.orcp.2026.09.004_bib3","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/s41591-022-02026-4","article-title":"Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial","volume":"28","author":"Garvey","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.orcp.2026.09.004_bib4","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/dom.14890","article-title":"Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses","volume":"25","author":"Kosiborod","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.orcp.2026.09.004_bib5","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"New Engl J Med"},{"key":"10.1016\/j.orcp.2026.09.004_bib6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/dc15-0258","article-title":"Markers of \u03b2-cell failure predict poor glycemic response to GLP-1 receptor agonist therapy in type 2 diabetes","volume":"39","author":"Jones","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.orcp.2026.09.004_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S2213-8587(22)00340-0","article-title":"Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials","volume":"11","author":"Dawed","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.orcp.2026.09.004_bib8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/dom.70141","article-title":"Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: The SEMALEAN study","volume":"28","author":"Alissou","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.orcp.2026.09.004_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015542","article-title":"Variants from GIPR, TCF7L2, DGKB, MADD, CRY2, GLIS3, PROX1, SLC30A8 and IGF1 are associated with glucose metabolism in the Chinese","volume":"5","author":"Hu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.orcp.2026.09.004_bib10","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s42255-025-01309-7","article-title":"Upper-gastrointestinal tract metabolite profile regulates glycaemic and satiety responses to meals with contrasting structure: a pilot study","volume":"7","author":"Cai","year":"2025","journal-title":"Nat Metab"},{"key":"10.1016\/j.orcp.2026.09.004_bib11","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/oby.20154","article-title":"High protein intake stimulates postprandial GLP1 and PYY release","volume":"21","author":"van der Klaauw","year":"2013","journal-title":"Obes (Silver Spring)"},{"key":"10.1016\/j.orcp.2026.09.004_bib12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2337\/db11-1019","article-title":"Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2","volume":"61","author":"Tolhurst","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.orcp.2026.09.004_bib13","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1186\/s12864-018-5327-0","article-title":"A high-fat diet alters genome-wide DNA methylation and gene expression in SM\/J mice","volume":"19","author":"Keleher","year":"2018","journal-title":"BMC Genom"},{"key":"10.1016\/j.orcp.2026.09.004_bib14","article-title":"Integrated multiomic analysis reveals the high-fat diet induced activation of the MAPK signaling and inflammation associated metabolic cascades via histone modification in adipose tissues","volume":"12","author":"Wang","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.orcp.2026.09.004_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33238-9","article-title":"Genome-wide methylation analysis identifies ELOVL5 as an epigenetic biomarker for the risk of type 2 diabetes mellitus","volume":"8","author":"Hwang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.orcp.2026.09.004_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.diabres.2019.01.008","article-title":"Differential methylation of the type 2 diabetes susceptibility locus KCNQ1 is associated with insulin sensitivity and is predicted by CpG site specific genetic variation","volume":"148","author":"Shah","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.orcp.2026.09.004_bib17","doi-asserted-by":"crossref","first-page":"E779","DOI":"10.1152\/ajpendo.90233.2008","article-title":"Incretin and islet hormonal responses to fat and protein ingestion in healthy men","volume":"295","author":"Carr","year":"2008","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"10.1016\/j.orcp.2026.09.004_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1677\/joe.0.1380159","article-title":"Glucagon-like peptide-1(7\u201336)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns","volume":"138","author":"Elliott","year":"1993","journal-title":"J Endocrinol"},{"key":"10.1016\/j.orcp.2026.09.004_bib19","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3390\/ijms25021087","article-title":"Nutrient combinations sensed by L-cell receptors potentiate GLP-1 secretion","volume":"25","author":"Sodum","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.orcp.2026.09.004_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbrc.2021.12.043","article-title":"Identification of a regulatory pathway of L-phenylalanine-induced GLP-1 secretion in the enteroendocrine L cells","volume":"588","author":"Osuga","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.orcp.2026.09.004_bib21","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0140-6736(87)91194-9","article-title":"Glucagon-like peptide-1 7-36: a physiological incretin in man","volume":"330","author":"Kreymann","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.orcp.2026.09.004_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/bbrc.1993.2226","article-title":"Cloning and functional expression of a human glucagon-like peptide-1 receptor","volume":"196","author":"Graziano","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.orcp.2026.09.004_bib23","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00125-003-1203-8","article-title":"Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector\/generator for glucose and GLP-1","volume":"46","author":"Delmeire","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.orcp.2026.09.004_bib24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2443.2009.01285.x","article-title":"Rab11 and its effector Rip11 participate in regulation of insulin granule exocytosis","volume":"14","author":"Sugawara","year":"2009","journal-title":"Genes Cells"},{"key":"10.1016\/j.orcp.2026.09.004_bib25","doi-asserted-by":"crossref","first-page":"46046","DOI":"10.1074\/jbc.M108378200","article-title":"Critical role of cAMP-GEFII\u00b7Rim2 complex in incretin-potentiated insulin secretion","volume":"276","author":"Kashima","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.orcp.2026.09.004_bib26","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1210\/en.2011-0259","article-title":"Glucagon-like peptide-1 enhances glucokinase activity in pancreatic \u03b2-cells through the association of Epac2 with Rim2 and Rab3A","volume":"153","author":"Park","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.orcp.2026.09.004_bib27","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4161\/isl.1.3.9645","article-title":"Glucose-dependent potentiation of mouse islet insulin secretion by Epac activator 8-pCPT-2\u2019-O-Me-cAMP-AM","volume":"1","author":"Kelley","year":"2009","journal-title":"Islets"},{"key":"10.1016\/j.orcp.2026.09.004_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4161\/isl.3.3.15507","article-title":"Phospholipase C-\u03b5 links Epac2 activation to the potentiation of glucose-stimulated insulin secretion from mouse islets of Langerhans","volume":"3","author":"Dzhura","year":"2011","journal-title":"Islets"},{"key":"10.1016\/j.orcp.2026.09.004_bib29","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1074\/jbc.M211682200","article-title":"Epac-selective cAMP Analog 8-pCPT-2\u2032-O-Me-cAMP as a stimulus for Ca2+-induced Ca2+ Release and Exocytosis in Pancreatic \u03b2-Cells","volume":"278","author":"Kang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.orcp.2026.09.004_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/03009734.2012.724732","article-title":"Cyclic AMP dynamics in the pancreatic \u03b2-cell","volume":"117","author":"Tengholm","year":"2012","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.orcp.2026.09.004_bib31","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00125-008-1149-y","article-title":"Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas","volume":"51","author":"de Heer","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.orcp.2026.09.004_bib32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1463-1326.2011.01454.x","article-title":"Physiologic action of glucagon on liver glucose metabolism","volume":"13","author":"Ramnanan","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.orcp.2026.09.004_bib33","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00125-017-4315-2","article-title":"The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice","volume":"60","author":"\u00d8rgaard","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.orcp.2026.09.004_bib34","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13852","article-title":"GLP-1 suppresses glucagon secretion in human pancreatic alpha-cells by inhibition of P\/Q-type Ca 2+ channels","volume":"6","author":"Ramracheya","year":"2018","journal-title":"Physiol Rep"},{"key":"10.1016\/j.orcp.2026.09.004_bib35","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.celrep.2019.07.009","article-title":"The GLP1R agonist liraglutide reduces hyperglucagonemia induced by the SGLT2 inhibitor dapagliflozin via somatostatin release","volume":"28","author":"Saponaro","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.orcp.2026.09.004_bib36","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.ijo.0801627","article-title":"The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity","volume":"25","author":"Flint","year":"2001","journal-title":"Int J Obes"},{"key":"10.1016\/j.orcp.2026.09.004_bib37","first-page":"R910","article-title":"GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans","volume":"277","author":"N\u00e4slund","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.orcp.2026.09.004_bib38","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1210\/jc.2005-2220","article-title":"Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses","volume":"91","author":"Little","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.orcp.2026.09.004_bib39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1210\/jc.2009-1503","article-title":"Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia","volume":"95","author":"Deane","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.orcp.2026.09.004_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.676869","article-title":"Gastrointestinal distension by pectin-containing carbonated solution suppresses food intake and enhances glucose tolerance via GLP-1 secretion and vagal afferent activation","volume":"12","author":"Ohbayashi","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.orcp.2026.09.004_bib41","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/npp.2016.246","article-title":"Endogenous glucagon-like peptide-1 receptor signaling in the nucleus tractus solitarius is required for food intake control","volume":"42","author":"Alhadeff","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.orcp.2026.09.004_bib42","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1463-1326.2004.00430.x","article-title":"Function of a long-term, GLP-1-treated, insulin-secreting cell line is improved by preventing DPP IV-mediated degradation of GLP-1","volume":"7","author":"Green","year":"2005","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.orcp.2026.09.004_bib43","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5483\/BMBRep.2009.42.4.212","article-title":"Fc fusion to Glucagon-like peptide-1 inhibits degradation by human DPP-IV, increasing its half-life in serum and inducing a potent activity for human GLP-1 receptor activation","volume":"42","author":"Kim","year":"2009","journal-title":"BMB Rep"},{"key":"10.1016\/j.orcp.2026.09.004_bib44","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1021\/acs.jmedchem.5b00726","article-title":"Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide","volume":"58","author":"Lau","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.orcp.2026.09.004_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00155","article-title":"The discovery and development of liraglutide and semaglutide","volume":"10","author":"Knudsen","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.orcp.2026.09.004_bib46","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1080\/07391102.2025.2532848","article-title":"Molecular dynamics insights into the binding interactions of semaglutide with human serum albumin","volume":"44","author":"Liu","year":"2026","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.orcp.2026.09.004_bib47","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140532","article-title":"Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist","volume":"5","author":"Willard","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.orcp.2026.09.004_bib48","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"New Engl J Med"},{"key":"10.1016\/j.orcp.2026.09.004_bib49","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.pcd.2022.10.005","article-title":"Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world","volume":"16","author":"Franch-Nadal","year":"2022","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.orcp.2026.09.004_bib50","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s00125-025-06448-w","article-title":"Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register \u2013 an IMI-SOPHIA study","volume":"68","author":"Heni","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/j.orcp.2026.09.004_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1547920","article-title":"Genetic variability in sodium-glucose cotransporter 2 and glucagon-like peptide 1 receptor effect on glycemic and pressure control in type 2 diabetes patients treated with SGLT2 inhibitors and GLP-1RA in the everyday clinical practice","volume":"16","author":"Tonin","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.orcp.2026.09.004_bib52","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41586-026-10330-z","article-title":"Genetic predictors of GLP1 receptor agonist weight loss and side effects","volume":"653","author":"Su","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.orcp.2026.09.004_bib53","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/hmg\/ddp178","article-title":"Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function","volume":"18","author":"Shu","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.orcp.2026.09.004_bib54","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1007\/s00125-007-0753-6","article-title":"Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms","volume":"50","author":"Sch\u00e4fer","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.orcp.2026.09.004_bib55","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.154314","article-title":"Hepatocyte-derived DPP4 regulates portal GLP-1 bioactivity, modulates glucose production, and when absent influences NAFLD progression","volume":"8","author":"Trzaskalski","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.orcp.2026.09.004_bib56","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.2337\/db11-1516","article-title":"Reduced insulin exocytosis in human pancreatic \u03b2-cells with gene variants linked to type 2 diabetes","volume":"61","author":"Rosengren","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.orcp.2026.09.004_bib57","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2337\/db08-1589","article-title":"Association of type 2 diabetes candidate polymorphisms in KCNQ1 with incretin and insulin secretion","volume":"58","author":"M\u00fcssig","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.orcp.2026.09.004_bib58","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1074\/jbc.M111.309369","article-title":"Second extracellular loop of human glucagon-like peptide-1 Receptor (GLP-1R) differentially regulates orthosteric but not allosteric agonist binding and function","volume":"287","author":"Koole","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.orcp.2026.09.004_bib59","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13611","article-title":"Glucose-induced cAMP elevation in \u03b2-cells involves amplification of constitutive and glucagon-activated GLP-1 receptor signalling","volume":"231","author":"Shuai","year":"2021","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.orcp.2026.09.004_bib60","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/s42255-023-00889-6","article-title":"Human GLP1R variants affecting GLP1R cell surface expression are associated with impaired glucose control and increased adiposity","volume":"5","author":"Gao","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/j.orcp.2026.09.004_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181190","article-title":"Insulin receptor signaling and glucagon-like peptide 1 effects on pancreatic beta cells","volume":"12","author":"Caporarello","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.orcp.2026.09.004_bib62","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2337\/db09-1169","article-title":"TCF7L2 Variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action","volume":"59","author":"Villareal","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.orcp.2026.09.004_bib63","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1007\/s00125-009-1307-x","article-title":"The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men","volume":"52","author":"Pilgaard","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.orcp.2026.09.004_bib64","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1007\/s00125-007-0832-8","article-title":"The enteroinsular axis may mediate the diabetogenic effects of TCF7L2 polymorphisms","volume":"50","author":"Nauck","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.orcp.2026.09.004_bib65","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1042\/BST0360357","article-title":"GA. TCF7L2 controls insulin gene expression and insulin secretion in mature pancreatic \u03b2-cells","volume":"36","author":"Loder","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.orcp.2026.09.004_bib66","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1007\/s00125-012-2600-7","article-title":"Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice","volume":"55","author":"da Silva Xavier","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.orcp.2026.09.004_bib67","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2337\/db12-0365","article-title":"The Wnt signaling pathway effector TCF7L2 controls gut and brain proglucagon gene expression and glucose homeostasis","volume":"62","author":"Shao","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.orcp.2026.09.004_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00386","article-title":"DPP4 in diabetes","volume":"6","author":"R\u00f6hrborn","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.orcp.2026.09.004_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113326","article-title":"GLP-1 and GIP receptors signal through distinct \u03b2-arrestin 2-dependent pathways to regulate pancreatic \u03b2 cell function","volume":"42","author":"Za\u00efmia","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.orcp.2026.09.004_bib70","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1038\/s41591-025-03645-3","article-title":"Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery","volume":"31","author":"German","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.orcp.2026.09.004_bib71","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.2337\/db20-0117","article-title":"Integrative analysis of glucometabolic traits, adipose tissue DNA methylation, and gene expression identifies epigenetic regulatory mechanisms of insulin resistance and obesity in African Americans","volume":"69","author":"Sharma","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.orcp.2026.09.004_bib72","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.2337\/db11-1653","article-title":"Impact of an exercise intervention on DNA methylation in skeletal muscle from first-degree relatives of patients with type 2 diabetes","volume":"61","author":"Nitert","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.orcp.2026.09.004_bib73","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13059-018-1389-1","article-title":"An obesity-associated gut microbiome reprograms the intestinal epigenome and leads to altered colonic gene expression","volume":"19","author":"Qin","year":"2018","journal-title":"Genome Biol"},{"key":"10.1016\/j.orcp.2026.09.004_bib74","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/jn\/136.6.1522","article-title":"A folate- and methyl-deficient diet alters the expression of DNA methyltransferases and methyl CpG binding proteins involved in epigenetic gene silencing in livers of F344 rats","volume":"136","author":"Ghoshal","year":"2006","journal-title":"J Nutr"},{"key":"10.1016\/j.orcp.2026.09.004_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155594","article-title":"A polyphenol-rich green Mediterranean diet enhances epigenetic regulatory potential: the DIRECT PLUS randomized controlled trial","volume":"145","author":"Hoffmann","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.orcp.2026.09.004_bib76","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13148-017-0321-y","article-title":"Maternal intake of methyl-group donors affects DNA methylation of metabolic genes in infants","volume":"9","author":"Pauwels","year":"2017","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.orcp.2026.09.004_bib77","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/1471-2407-13-389","article-title":"Plasma S-adenosylmethionine, DNMTpolymorphisms, and peripheral blood LINE-1 methylation among healthy Chinese adults in Singapore","volume":"13","author":"Inoue-Choi","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.orcp.2026.09.004_bib78","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/S0007114519002526","article-title":"DNA methylation and one-carbon metabolism related nutrients and polymorphisms: analysis after mandatory flour fortification with folic acid","volume":"123","author":"Steluti","year":"2020","journal-title":"Br J Nutr"},{"key":"10.1016\/j.orcp.2026.09.004_bib79","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.2011.39.3090","article-title":"Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia","volume":"30","author":"Claus","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.orcp.2026.09.004_bib80","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/jn\/131.11.2811","article-title":"Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice","volume":"131","author":"Caudill","year":"2001","journal-title":"J Nutr"},{"key":"10.1016\/j.orcp.2026.09.004_bib81","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2337\/db16-0776","article-title":"Placental and cord blood methylation of genes involved in energy homeostasis: association with fetal growth and neonatal body composition","volume":"66","author":"D\u00edaz","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.orcp.2026.09.004_bib82","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1007\/s00125-014-3299-4","article-title":"Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes","volume":"57","author":"Omar","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.orcp.2026.09.004_bib83","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jnutbio.2018.09.025","article-title":"Epigenetic regulation of hepatic Dpp4 expression in response to dietary protein","volume":"63","author":"Saussenthaler","year":"2019","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.orcp.2026.09.004_bib84","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2337\/db15-1716","article-title":"Hepatic DPP4 DNA methylation associates with fatty liver","volume":"66","author":"Baumeier","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.orcp.2026.09.004_bib85","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2350-14-76","article-title":"DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic islets","volume":"14","author":"Hall","year":"2013","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.orcp.2026.09.004_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2980","article-title":"Methylation of Tcf712 promoter by high-fat diet impairs \u03b2-cell function in mouse pancreatic islets","volume":"34","author":"Hu","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.orcp.2026.09.004_bib87","first-page":"7563","article-title":"Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines","volume":"63","author":"Fang","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.orcp.2026.09.004_bib88","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1124\/mol.104.008367","article-title":"Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids","volume":"68","author":"Lee","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.orcp.2026.09.004_bib89","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bmcl.2008.12.041","article-title":"Curcumin is a potent DNA hypomethylation agent","volume":"19","author":"Liu","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.orcp.2026.09.004_bib90","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ijc.24398","article-title":"Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms","volume":"125","author":"Li","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.orcp.2026.09.004_bib91","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1186\/s12885-015-1693-z","article-title":"Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent \u03b3-H2AX and telomerase regulation in triple-negative breast cancer","volume":"15","author":"Kala","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.orcp.2026.09.004_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.153058","article-title":"Crucifera sulforaphane (SFN) inhibits the growth of nasopharyngeal carcinoma through DNA methyltransferase 1 (DNMT1)\/Wnt inhibitory factor 1 (WIF1) axis","volume":"63","author":"Chen","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.orcp.2026.09.004_bib93","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/biom9120865","article-title":"Long-lasting effects of GSPE on Ileal GLP-1R gene expression are associated with a hypomethylation of the GLP-1R promoter in female wistar rats","volume":"9","author":"Gin\u00e9s","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.orcp.2026.09.004_bib94","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/38444","article-title":"Crystal structure of the nucleosome core particle at 2.8\u2009\u00c5 resolution","volume":"389","author":"Luger","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.orcp.2026.09.004_bib95","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2007.05.009","article-title":"High-resolution profiling of histone methylations in the human genome","volume":"129","author":"Barski","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.orcp.2026.09.004_bib96","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0021-9258(18)54150-8","article-title":"Studies of the DNA binding properties of histone H4 amino terminus. Thermal denaturation studies reveal that acetylation markedly reduces the binding constant of the H4 \u201ctail\u201d to DNA","volume":"268","author":"Hong","year":"1993","journal-title":"J Biol Chem"},{"issue":"1979","key":"10.1016\/j.orcp.2026.09.004_bib97","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1126\/science.1164097","article-title":"ATP-citrate lyase links cellular metabolism to histone acetylation","volume":"324","author":"Wellen","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.orcp.2026.09.004_bib98","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0092-8674(00)80551-6","article-title":"Histone octamer transfer by a chromatin-remodeling complex","volume":"96","author":"Lorch","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.orcp.2026.09.004_bib99","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0092-8674(78)90305-7","article-title":"Sodium butyrate inhibits histone deacetylation in cultured cells","volume":"14","author":"Candido","year":"1978","journal-title":"Cell"},{"key":"10.1016\/j.orcp.2026.09.004_bib100","first-page":"227","article-title":"Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects","volume":"232","author":"Myzak","year":"2007","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.orcp.2026.09.004_bib101","doi-asserted-by":"crossref","first-page":"51163","DOI":"10.1074\/jbc.M409024200","article-title":"Curcumin, a Novel p300\/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone\/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.orcp.2026.09.004_bib102","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1074\/jbc.M116.750620","article-title":"Impact of a high-fat diet on tissue Acyl-CoA and histone acetylation levels","volume":"292","author":"Carrer","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.orcp.2026.09.004_bib103","doi-asserted-by":"crossref","DOI":"10.1172\/JCI177980","article-title":"BAF60a-dependent chromatin remodeling preserves \u03b2 cell function and contributes to the therapeutic benefits of GLP-1R agonists","volume":"135","author":"Qiu","year":"2025","journal-title":"J Clin Investig"},{"key":"10.1016\/j.orcp.2026.09.004_bib104","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1007\/s00125-011-2250-1","article-title":"Exendin-4 increases histone acetylase activity and reverses epigenetic modifications that silence Pdx1 in the intrauterine growth retarded rat","volume":"54","author":"Pinney","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.orcp.2026.09.004_bib105","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.orcp.2026.09.004_bib106","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41586-020-2604-2","article-title":"Microbiota-derived metabolite promotes HDAC3 activity in the gut","volume":"586","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.orcp.2026.09.004_bib107","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/ismej.2010.118","article-title":"Dominant and diet-responsive groups of bacteria within the human colonic microbiota","volume":"5","author":"Walker","year":"2011","journal-title":"ISME J"},{"key":"10.1016\/j.orcp.2026.09.004_bib108","doi-asserted-by":"crossref","first-page":"E1160","DOI":"10.1152\/ajpendo.90637.2008","article-title":"Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents","volume":"295","author":"Zhou","year":"2008","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"10.1016\/j.orcp.2026.09.004_bib109","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ijo.2014.153","article-title":"The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents","volume":"39","author":"Psichas","year":"2015","journal-title":"Int J Obes"},{"key":"10.1016\/j.orcp.2026.09.004_bib110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut Microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.orcp.2026.09.004_bib111","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.orcp.2026.09.004_bib112","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1038\/ncomms8629","article-title":"Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells","volume":"6","author":"Trabelsi","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.orcp.2026.09.004_bib113","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41598-019-56743-x","article-title":"The nuclear receptor FXR inhibits glucagon-like peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids","volume":"10","author":"Ducastel","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.orcp.2026.09.004_bib114","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.orcp.2026.09.004_bib115","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.celrep.2017.10.008","article-title":"Enteroendocrine L cells sense LPS after gut barrier injury to enhance GLP-1 secretion","volume":"21","author":"Lebrun","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.orcp.2026.09.004_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029837","article-title":"Modulation of miRNA expression by dietary polyphenols in apoE deficient mice: a new mechanism of the action of polyphenols","volume":"7","author":"Milenkovic","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.orcp.2026.09.004_bib117","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/db17-0506","article-title":"miR-204 controls glucagon-like peptide 1 receptor expression and agonist function","volume":"67","author":"Jo","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.orcp.2026.09.004_bib118","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41419-020-03366-0","article-title":"MicroRNA-194: a novel regulator of glucagon-like peptide-1 synthesis in intestinal L cells","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.orcp.2026.09.004_bib119","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.cell.2007.05.022","article-title":"Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs","volume":"129","author":"Rinn","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.orcp.2026.09.004_bib120","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.celrep.2016.01.062","article-title":"A long non-coding RNA, lncLGR, regulates hepatic glucokinase expression and glycogen storage during fasting","volume":"14","author":"Ruan","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.orcp.2026.09.004_bib121","article-title":"LncRNA and mRNA expression profiles in brown adipose tissue of obesity-prone and obesity-resistant mice","volume":"25","author":"Wang","year":"2022","journal-title":"IScience"},{"key":"10.1016\/j.orcp.2026.09.004_bib122","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.3390\/nu15173707","article-title":"An association between decreased small intestinal rna modification and disturbed glucagon-like peptide-1 secretion under high-fat diet stress","volume":"15","author":"Chen","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.orcp.2026.09.004_bib123","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1111\/dom.16275","article-title":"Body composition changes during weight reduction with tirzepatide in the SURMOUNT -1 study of adults with obesity or overweight","volume":"27","author":"Look","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.orcp.2026.09.004_bib124","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3945\/ajcn.115.106799","article-title":"The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans","volume":"102","author":"Mand\u00f8e","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.orcp.2026.09.004_bib125","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48775-0","article-title":"Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans","volume":"9","author":"M\u00fcller","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.orcp.2026.09.004_bib126","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1186\/s12967-026-07702-4","article-title":"Dietary intake patterns and nutritional adequacy among adults with overweight or obesity treated with GLP-1 or dual GIP\/GLP-1 receptor agonists- preliminary study","volume":"24","author":"Korus","year":"2026","journal-title":"J Transl Med"}],"container-title":["Obesity Research & Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871403X26000888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871403X26000888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:56:36Z","timestamp":1790196996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871403X26000888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":126,"alternative-id":["S1871403X26000888"],"URL":"https:\/\/doi.org\/10.1016\/j.orcp.2026.09.004","relation":{},"ISSN":["1871-403X"],"issn-type":[{"value":"1871-403X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic determinants of GLP-1 responsiveness: Integrating dietary modulation beyond genetics","name":"articletitle","label":"Article Title"},{"value":"Obesity Research & Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.orcp.2026.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Asia Oceania Association for the Study of Obesity. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}